Friday, October 30, 2026 · Edition updated 6:00 AM ETFRI, OCT 30 · 6 AM ET editionNext edition in Next --:--:--

Red light therapy and aging: what a review of past studies found

A summary of earlier studies · Molecular neurobiology · Oct 29, 2026

What this means

This review looks at past studies of red and near-infrared light on aging-linked conditions. It says the results are promising, but treatment methods are not yet standard.

Plain-English summary written by an AI model from the abstract. The original is below.

Tested inSummary of earlier studies
Who it was tested in
A review of past studies in cells, animals, and people
Kind of research
A summary of earlier studies

The science

Original title
Red Light Therapy and Mitochondrial Rejuvenation in Age-Related Disorders.
Authors
Iglewska M, Flis KA, Kołakowska M et al.
Journal
Molecular neurobiology
Published
Oct 29, 2026
Study type
Review · in humans

Abstract

Aging is associated with mitochondrial dysfunction, impaired ATP production, and a decline in tissue regenerative capacity, leading to the development of age-related diseases. This review summarizes current evidence regarding the effects of photobiomodulation (PBM) on mitochondrial function and age-related disorders. PBM using red and near-infrared light may enhance proper mitochondrial function by acting on cytochrome c oxidase (CCO) and other signaling pathways, including the transient receptor potential vanilloid 1 (TRPV1) channel, leading to increased ATP production, modulation of ROS signaling, and improved cellular homeostasis. We review in vitro, animal, and clinical studies investigating PBM in metabolic, neurodegenerative, hepatic, cardiovascular, age-related macular degeneration (AMD), and skeletal muscle disorders associated with aging, as well as its application in the management of cancer therapy-related oral mucositis. Current studies demonstrate beneficial effects on glucose metabolism, cardiovascular function, neuronal function, lipid metabolism, liver function, muscle regeneration, and visual function in AMD, as well as the safety and efficacy of PBM in the management of cancer therapy-induced oral mucositis. The therapeutic effects of PBM appear to be dose-dependent and influenced by treatment parameters including wavelength, fluence, irradiance, and exposure protocol. Although photobiomodulation still lacks standardized treatment protocols and differences exist in the wavelengths used, dosage, and frequency among studies, it represents a promising therapeutic approach for the treatment of age-related diseases.

Read it on PubMed ↗

Iglewska M, Flis KA, Kołakowska M et al. Red Light Therapy and Mitochondrial Rejuvenation in Age-Related Disorders. Molecular neurobiology. 2026. doi:10.1007/s12035-026-06294-w. PMID: 42955214. https://pubmed.ncbi.nlm.nih.gov/42955214/

Related research

See all research on Red light therapy →

Report a problem